Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to a minority of cancer patients. The current priority is to understand why the majority of patients fail to respond. Besides T-cell dysfunction, T-cell apoptosis was reported in several recent studies a...
主要な著者: | Zhu, J, Petit, P, Van Den Eynde, B |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Berlin Heidelberg
2018
|
類似資料
-
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
著者:: Zhu, J, 等
出版事項: (2017) -
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
著者:: Jingjing Zhu, 等
出版事項: (2017-11-01) -
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
著者:: Jeroen F. Vermeulen, 等
出版事項: (2018-03-01) -
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
著者:: Ioana Plesca, 等
出版事項: (2020-03-01) -
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
著者:: Yunyan Dai, 等
出版事項: (2025-01-01)